Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DP-QB-MYA-002 Phage Cocktail for Chronic Multidrug-Resistant (MDR) Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection

NCT07429162 is registered in ClinicalTrials.gov with Alberta Health services as lead sponsor.

NCT NCT07429162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07429162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DP-QB-MYA-002 Phage Cocktail for Chronic Multidrug-Resistant (MDR) Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection
Lead sponsor
Alberta Health services
Phase
Phase 1
Overall status
Not yet recruiting
Start date
July 2, 2026
Completion date
July 2, 2028
Enrollment
1 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bacteriophage therapy, mycobacterium abscessus infection, pulmonary disease